Gleamer Joins Prestigious French Tech Next 120 Program and Internal Funding to Accelerate Global AI Radiology Vision

Paris, June 5, 2025

Gleamer, a global leader in AI-powered medical imaging, proudly announces its selection to the French Tech Next 120, France’s flagship scale-up program spotlighting the nation’s most promising tech champions. This elite recognition cements Gleamer’s position at the forefront of digital health and reinforces its bold mission to redefine radiology through AI on a global scale.

Working with nearly 60 partners of the French Tech Mission, the program aims to support companies in their development challenges in France and internationally, increase their visibility, promote meetings with decision-makers, and encourage the sharing of experiences among peers. It also raises awareness and promotes the actions of these companies on issues of gender equality and ecological transition.

Simultaneously, Gleamer has secured a new internal fundraising round, backed by continued confidence from its existing investors. The funds will supercharge the company’s global expansion, fuel the integration of recent strategic acquisitions, and accelerate the rollout of its cutting-edge Gleamer Copilot® platform across all major imaging modalities.

Building on exceptional momentum, having already reached €20 million in signed annual recurring revenue (ARR) as of December 2024, Gleamer is targeting €35 million signed ARR by year-end, reinforcing its position as one of the fastest-growing companies in AI-driven healthcare.

“Being selected for French Tech Next 120 is a powerful validation of our mission to reinvent radiology with AI,” said Christian Allouche, CEO and co-founder of Gleamer. “With this new funding and our accelerating growth, we’re uniquely positioned to scale the most comprehensive and clinically proven AI suite in the imaging industry.”

A Unified Gleamer Copilot® for All Major Imaging Modalities

With the strategic acquisitions of Pixyl (neuro MRI) and Caerus Medical (musculoskeletal MRI), Gleamer is now the first AI provider offering a proprietary certified portfolio spanning X-ray, Mammography, CT, and MRI.

This convergence allows Gleamer to deliver a consistent, high-performance Gleamer Copilot® experience across the entire radiology workflow - enhancing diagnostic accuracy, reducing turnaround times, and improving patient outcomes at scale.

About Gleamer

Founded in 2017, Gleamer considers AI to be a key solution for addressing the sharp rise in demand for medical imaging, stemming from the challenges of an ageing population, the increasing prevalence of chronic diseases, and the problems of access to healthcare. The company's suite of AI-powered solutions, across X-Ray, Mammography, CT and MRI, supports radiologists and clinicians in their diagnoses, thereby improving reliability and reducing the time taken to read and process examinations. The relevance and exceptional performance of these solutions have been recognised worldwide thanks to 36 publications in highly regarded peer-reviewed journals. 

Recognized through over 36 peer-reviewed publications and adopted by more than 2,500 institutions in 49 countries, Gleamer’s technology has already analyzed over 40 million exams. The company is setting new standards for accuracy, efficiency, and innovation in the medical imaging field.

For more information, visit gleamer.ai.

For the latest regulatory information about Gleamer’s solutions, please refer to this website: gleamer.ai/privacy-policy 

About French Tech Next 40/120

Launched in 2019 by the French Tech Mission, French Tech Next 40/120 is a government support program dedicated to the 120 most successful French startups with the potential to become international leaders.

For more information, visit https://lafrenchtech.gouv.fr/fr/programme/french-tech-next-40-120/ 

Media Contact – Agence Raoul

Alyssa Zayani – alyssa@agenceraoul.com – +33.6.59.09.00.56

Alexandre Costes – alexandre@agenceraoul.com – +33.6.72.71.97.98